How a British team discovered the first life-saving coronavirus drug

-
In just three months, the UK-based Recovery trial identified that dexamethasone had a dramatic impact on Covid-19 survival rates

from WIRED UK https://ift.tt/3dHhA5R

Comments

Post a Comment

Popular posts from this blog

5 investors discuss what’s in store for venture debt following SVB’s collapse

-
There are many questions around the implications of Silicon Valley Bank’s (SVB) collapse that won’t be answered for a long time. But there’s one question that many startups and investors are hoping will get answered sooner rather than later: What happens to venture debt? SVB was one of the larger, if not the largest, providers of venture debt to U.S.-based startups. And now that First Republic Bank has also gone under, that question has spiraled, growing ever more complex. Many startups rely on venture debt: it’s both a cheaper alternative to raising equity and can serve as a capital tool that helps companies build in ways that equity isn’t great for. For some companies in capital-intensive areas like climate, fintech and defense, access to debt is often the only avenue to growth or scale. Thankfully, venture capitalists aren’t too worried about the SVB collapse’s impact on venture debt as a whole. We’re widening our lens, looking for more investors to participate in TechCrunch su...
Read more

Taking the pulse on the Northeast seed market with Techstars’ Kerty Levy

-
Techstars’ Kerty Levy knows a thing or two about where seed funding is, and where it might be going, in the Northeast. During a presentation at TechCrunch’s Early Stage in Boston last month, Levy took a brief look at deal counts and valuations before exploring in more depth what the obstacles to funding are right now, and what founders are going to have to expand on in order to cut a deal. From 2021 to 2022, overall deal count in the Northeast was down around 25%. It might not be surprising, but it is quite stark. If you take a look at seed funding specifically, things are even more contracted. “Even if you extrapolate out past this quarter, even if we have a great second half of the year, I’m afraid that the deal count is looking bad,” she said. In the first quarter of 2023, most of the investments in New England were in the productivity, business productivity, software, health care, climate, energy and fintech sectors. But in Levy’s opinion, founders seeking investment are expec...
Read more